Yahoo Web Search

Search results

1. • Small Business - Cordele Dispatch | Cordele Dispatch

     Cordele Dispatch· 1 day ago

     Sixteen Researchers from Florida Cancer Specialists & Research Institute Share Cancer Care Discoveries at 2024 ASCO® Annual Meeting PR Newswire FORT MYERS, Fla., May 29, 2024 37 Cutting-Edge Study Results Presented at Global Gathering, Six Oral

2. • Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing ...

     WKRN Nashville· 6 days ago

     Novartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G study of Fabhalta® (iptacopan) at the late-breaking clinical trials session ...

3. • 

     Earnings call: CollPlant reports Q1 2024 results and corporate updates By Investing.com

     Investing.com· 1 day ago

     CEO Yehiel Tal highlighted the company's progress in the development of regenerative medical...

4. • Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further...

     The Woonsocket Call· 6 days ago

     In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1% proteinuria (protein in urine) reduction vs. placebo + supportive

5. • Medical Device Coatings Company, Hydromer Inc, Launches New Product HydroThrombX

     Digital Journal· 1 day ago

     North of Soledar, Ukrainians yearn for peace Carlo Marks talks about his new Hallmark movie ‘The Wedding Veil Inspiration’ Musk faces US fraud trial over Tesla tweet Heat ...

6. • 

     Pennsylvania boy is headed to California for a clinical trial that might help save his life | Helen...

     Philly.com· 6 days ago

     This isn’t the column I was hoping to write after introducing readers to Jax Ramirez in 2022, a...

7. • 

     Ozempic reduces risk of serious illness and death in people with diabetes and kidney disease, study...

     CNN.com· 7 days ago

     Weekly injections of semaglutide medications like Ozempic significantly reduce the risk of serious...

8. • 

     Medtronic's (MDT) OmniaSecure Lead Favored in the LEADR Trial

     Zacks via Yahoo Finance· 7 days ago

     Presently, it is investigational worldwide and not yet approved for sale or distribution. More on...

9. • Ozempic Lowers Odds for Death, Illness in People With Kidney Disease and Type 2 Diabetes

     US News & World Report· 7 days ago

     Ozempic provides a wide variety of health benefits for people with kidney disease and type 2 diabetes, a major clinical trial has found. The drug significantly ...

10. • 

      Carefully Designing De-escalation Trials in Breast Cancer

      Medscape· 22 hours ago

      De-escalation trials in early breast cancer are "critical to preserving quality of life" but require...